“a decreasing trend”

Over a 48-month follow-up period, all three groups showed a decreasing trend in knee JSW, with the IACI group having the fastest JSW decline rate at -0.020 mm/month (95% CI: -0.027 to -0.013, p < 0.01).

Among the six smaller production regions, Denver-Julesburg also shows a decreasing trend with P < 0.01, while the others show insignificant trends ( SI Appendix , Table S4 ).

Between sessions one and three, all of the three techniques showed a decreasing trend of SpO 2 scores, with the exception of the pharmacological management of ADHD children (p<0.01) indicating that the uncontrollable ADHD children feel less anxious than in the other two approaches.

In SEER, among those <55 years, incidence increased at a higher rate in women (AAPC = 3.22%, p < 0.01) than men (AAPC = 1.51%, p = 0.03), with non-parallel trends ( p = 0.02), while a decreasing trend was seen in both men (AAPC = −2.16%, p < 0.01) and women (AAPC = −1.37%, p < 0.01) of the ≥55 years group.

Furthermore, the levels of SNRPD1 in each group showed a decreasing trend with the increase in treatment time ( P < 0.01) ( Figure 2G ).

Starting from the third week, the levels of fasting blood glucose in mice receiving EcN-GLP-1 treatment showed a decreasing trend and were notably lower compared to the M group (21.0 mmol/L versus 24.7 mmol/L, p < 0.01) ( Figure 4(b) ).

RBC counts exhibited a decreasing trend, with a significant reduction in the HD group compared to Con ( p < 0.01) ( Figure 9 A).

For men, there was a decreasing trend in AAMR from 1999 to 2012 (APC -0.98, 95 %CI: −1.31 to −0.69) (p value = 0.010398).

However, there was a difference in the pre-PDSA cycles, with the opioid stewardship programme hospital presenting higher inpatient opioid consumption (average of 16 mg oral morphine equivalents higher; 95% CI 5 to 27; p=0.008) but a decreasing trend of −2 mg oral morphine equivalents per month (95% CI −4 to –0.6; p=0.011) compared with the control hospital.

pneumoniae , the resistance rate to imipenem and meropenem significantly increased in 2019 ( p < 0.05), while that to cefoperazone/sulbactam showed a decreasing trend during the study period ( p = 0.0110) ( Figure 4 C).

Additionally, with each year increase in patients’ age, their costs have shown a decreasing trend ( p value = 0.011) (Table 4 ). 3.4.

A decreasing trend was shown in NHB ( P = 0.011) from 2006 to 2016.

However, a decreasing trend in 100‐day mortality was observed, with improved DSS over the study period (1988–2002 compared with 2003–2017, p = 0.011), despite increased median age at PTLD diagnosis.

TRAb levels showed a decreasing trend, albeit not statistically significant (Cohen’s d = 0.71, p = 0.012) (Table 4 ).

Positive rates of epithelial Cav-1 in gastritis without IM, gastritis with IM and GC showed a decreasing trend ( P = 0.012).

Waist circumference showed a decreasing trend from Q1 to Q4 (102.03 ± 14.48 cm to 100.22 ± 15.99 cm; P = 0.012), while BMI remained comparable across quartiles ( P = 0.860).

Hippocampal WB analysis ( Figure 3A ) revealed significant age-dependent upregulation of cuproptosis regulators in 18M+WT mice versus young controls: FDX1 increased [One-way ANOVA: F (2, 13) = 8.739, p = 0.0039; Figures 3B,C ]; LIAS increased [One-way ANOVA: F (2, 13) = 10.95, p = 0.0016; Figures 3B,D ]; DLAT showed a decreasing trend [One-way ANOVA: F (2, 13) = 6.248, p = 0.01225; Figures 3B,E ].

Estimating the effect of ALD, NAFLD, and potential mediators on BMD As shown in Fig 2 , genetically determined ALD was significantly associated with a decreasing trend of FN-BMD at the Bonferroni corrected significance of P < 0.0125 (IVW beta = -0.0288; 95% CI: -0.0488, -0.00871; P = 0.00494).

Serological response In all enrolled patients, HBeAg showed a decreasing trend at 24 ± 2w and 48 ± 2w ( χ 2 = 8.715, p = 0.013) compared with baseline.

Results The latent variable growth model showed a decreasing trend in frailty (S = −0.197, p = 0.013) and an increasing trend in postoperative cognitive function (S = 0.124, p = 0.002) from T1 to T3 in elderly spinal surgery patients; at the initial level, frailty was negatively correlated with cognitive function ( r = −0.452, p < 0.001), and initial levels of fra

In addition, MSHQ-Bother scores showed a decreasing trend over time, reaching statistical significance at 12 months ( p = 0.013), reflecting a reduction in patients’ bother related to ejaculatory issues.

In the multivariable GLMM analysis, switching regimens was associated with an increasing trend in TC (P < 0.001) and a decreasing trend in GLU (P = 0.013).

A structured and supervised program lasting 6 weeks, which included body-awareness training, massages, relaxation techniques, and resistance and fitness training, showed a decreasing trend in myalgia ( p = 0.013) and pain ( p = 0.013) levels within 6 weeks [ 34 ], as well as in peripheral neuropathy immediately after the intervention ( p = 0.028) and at 4 weeks ( p = 0.031) [ 77 ].

The average number of cases was 33 ± 23 per year, with a decreasing trend over the years ( p = 0.0131; Figure 1 ).

Correspondingly, postoperative bleeding rates showed a decreasing trend after 2016, during which ALL bleeding was significantly reduced (52.9% before 2015 vs. 33.6% after 2016, p = 0.014).